type a personal note here to prepend to the story:

-----------------
VENTUREWIRE
Tuesday, March 02, 2004

o Cytyc Agrees to Buy Device Firm Novacept in $325M Cash Deal

Boxborough, Mass. (VENTUREWIRE) -- Cytyc, a publicly held company that develops cervical cancer screening technology for medical diagnostic applications, said it has entered into an agreement to acquire Palo Alto, Calif.-based Novacept, a provider of devices for the treatment of excessive menstrual bleeding that raised $73 million in funding. The all-cash deal is valued at roughly $325 million.

http://www.cytyc.com

http://www.novacept.com

Subscribe to the best sources of venture-capital and private company news and data available:
http://venturewire.com/

©2010 Dow Jones & Company, Inc